Psycho-Education with Problem Solving (PEPS) therapy for personality disorder | Not Recruiting
Psycho-Education with Problem Solving (PEPS) therapy for personality disorder
PEPS
Trial Source

There is no location for this trial

Location data is sourced from multiple external providers and UKCTG is not responsible for and cannot guarantee the accuracy of data.

Health Conditions
  • Personality disorder
Prof Mary McMurran
See all trial contact details
Primary Contact Details
Not Recruiting
Recruitment Status
ISRCTN70660936
Primary Trial ID Number
Summary
STUDY SUMMARY tab on http://www.peps-trial.co.uk/
Research Details
  • The purpose of the trial is to evaluate the effectiveness of PEPS therapy compared with treatment as usual in improving social functioning in community based adults with personality disorder. Please note, as of 23/06/2011 various updates have been made to this trial and can be found under this date of update in the relevant fields below.
Phase
Not Applicable
Study Design
Multicentre two-arm parallel group randomised controlled trial
Study Type
Interventional
Intervention

Psycho-education combined with problem solving (PEPS) therapy is a complex cognitive-behavioural intervention that integrates individual and group therapies. Psycho-education consists of up to 4 sessions of an individual collaborative dialogue designed to build a rapport with patients, inform them about their personality disorder, discuss its effects on interpersonal relationships and social functioning, and enhance motivation for therapy. Problem solving therapy is a 12-session group intervention designed to teach people strategies for solving interpersonal problems. Throughout the twelve week problem solving therapy group sessions, participants are offered additional, optional fortnightly individual support sessions with a group facilitator. PEPS therapy will be compared with treatment as usual. (Added 23/06/2011; previous intervention for this point can be found below). Follow-up assessments for all participants will be completed after the initial treatment phase (weeks 5 - 10), immediately after the second treatment phase (during weeks 24 - 26) and again four and twelve months after the end of the intervention. Previous intervention: PEPS therapy will be compared with a standardised form of 'treatment as usual' which will include an initial care planning session with a mental health worker, including plans for future contact with services and details of alternative sources of help and support, with a follow-up session after approximately 4 weeks and a further session approximately 4 months later with additional telephone support.

Intervention Type
Other
Primary Outcome Measures
  • Social functioning as measured by the Social Functioning Questionnaire (SFQ). This is an 8-item self-report scale, each item scored on a scale from 0 to 3. A reduction (i.e. an improvement) of 2 points or more on the SFQ at 1 year, post-treatment follow-up is the specified clinically significant change.
Secondary Outcome Measures
  • 1. Receipt and cost of services post-therapy and at one year follow-up measured by the Client Service Receipt Inventory
  • 2. Scheduled and unscheduled service use post-therapy and at one year follow-up measured by the Client Service Receipt Inventory and a service use record check.
  • 3. Quality of life post-therapy and at one year follow-up measured by the EQ-5D
  • 4. Referrer's ratings of functioning post-therapy and at one year follow-up measured by the Global Assessment of Functioning
  • 5. Anxiety and depression post-therapy and at one year follow-up meaured by the Hospital Anxiety and Depression Scale
  • 6. A rating of the client's self-assessment of problems post-therapy and at one year follow-up
Publication(s)
2011 protocol in http://www.ncbi.nlm.nih.gov/pubmed/21864370
Result Reports
Sorry, this information is not available
Gender
Both
Age Range
Adult
Who Can Participate
Patient
Number of Participants
340
Participant Inclusion Criteria
  • 1. Living in the community
  • 2. Presence of one or more personality disorder, as identified by the International Personality Disorder Examination
  • 3. Aged 18 years or over, either sex
  • 4. Proficiency in spoken English is necessary for trial participation due to the requirements of the interventions used
  • 5. Capacity to provide valid informed consent
Participant Exclusion Criteria
  • Current exclusion criteria as of 23/06/2011:
  • 1. Primary diagnosis of major functional psychosis
  • 2. Insufficient degree of literacy, comprehension or attention to be able to engage in trial therapy and assessments
  • 3. Currently engaged in psychological treatment for personality disorder, or likely to start such treatment during the trial period
  • 4. Already enrolled in any other trial
  • Previous exclusion criteria:
  • 1. Insufficient degree of literacy, comprehension or attention to be able to engage in trial therapy and assessments, as assessed by the Investigator or authorised designee in conjunction with the participants usual care team. This may be a result of psychosis, developmental disability, organic brain disorder, substance use, or any other disorder or disability.
  • 2. Currently engaged in psychological treatment for personality disorder, or likely to start such treatment during the trial period
  • 3. Already enrolled in any other trial
Trial Location(s)
Nottingham
NG7 2TU
Trial Contact(s)
Primary Trial Contact
Prof Mary McMurran
Other Trial Contacts
Sorry, this information is not available
Countries Recruiting
United Kingdom
Scientific Title
Psycho-Education with Problem Solving (PEPS) therapy for adults with personality disorder: a community-based randomised controlled trial
EudraCT Number
Sorry, this information is not available
Funder(s)
  • NIHR Health Technology Assessment Programme - HTA (UK)
Other Study ID Numbers
HTA 08/53/06
Sponsor(s)
Nottinghamshire Healthcare NHS Trust (UK)
Key Dates

Recruitment Start Date

01 Aug 2010

Recruitment End Date

31 Jan 2014

Trial Start Date

01 Aug 2010

Trial End Date

31 Jan 2014

Date Assigned

03 Dec 2009

Last Updated

12 Sep 2012